期刊
PHARMACEUTICALS
卷 15, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/ph15111348
关键词
in silico; emodin; chrysophanol; colorectal cancer; cervical carcinoma
资金
- Deanship of Scientific Research at King Khalid University
- [RGP.1/165/43]
In this study, anthraquinone derivatives chrysophanol (Chr) and emodin (EM) showed strong anti-cancer effects and had better binding energies than the FDA-approved anticancer drug fluorouracil, according to molecular docking studies. In vitro experiments confirmed the promising anticancer activity of Chr and EM in HCT-116 and HeLa cells, laying the foundation for their potential use in the treatment of human colorectal and cervical carcinomas.
Anthraquinones (AQs) are present in foods, dietary supplements, pharmaceuticals, and traditional treatments and have a wide spectrum of pharmacological activities. In the search for anti-cancer drugs, AQ derivatives are an important class. In this study, anthraquinone aglycons chrysophanol (Chr), emodin (EM) and FDA-approved anticancer drug fluorouracil were analyzed by molecular docking studies against receptor molecules caspase-3, apoptosis regulator Bcl-2, TRAF2 and NCK-interacting protein kinase (TNIK) and cyclin-dependent protein kinase 2 (CDK2) as novel candidates for future anticancer therapeutic development. The ADMET SAR database was used to predict the toxicity profile and pharmacokinetics of the Chr and EM. Furthermore, in silico results were validated by the in vitro anticancer activity against HCT-116 and HeLa cell lines to determine the anticancer effect. According to the docking studies simulated by the docking program AutoDock Vina 4.0, Chr and EM had good binding energies against the target proteins. It has been observed that Chr and EM show stronger molecular interaction than that of the FDA-approved anticancer drug fluorouracil. In the in vitro results, Chr and EM demonstrated promising anticancer activity in HCT-116 and HeLa cells. These findings lay the groundwork for the potential use of Chr and EM in the treatment of human colorectal and cervical carcinomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据